Macrophage polarization in disease therapy: insights from astragaloside IV and cycloastragenol
Dysregulated activation and polarization of macrophages drive the pathogenesis of diverse diseases, including inflammatory, autoimmune, ischemic, metabolic disorders, and cancers. Despite therapeutic advances, precise regulation of macrophage polarization remains challenging. Natural products have r...
Saved in:
| Main Authors: | Bei-Bei Xiong, Yu-Mei Zhuo, Huan Wang, Qiao-Ling Zheng, Feng Tang, Qun Huang, Man Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1598022/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Astragaloside IV: a potential nemesis for gastric cancer
by: Chao Hu, et al.
Published: (2025-07-01) -
Astragaloside IV mitigates influenza-induced inflammatory responses by suppressing the Wnt/β-catenin signalling pathway in alveolar macrophages
by: Jianli Tang, et al.
Published: (2025-04-01) -
Astragaloside IV represses hepatocellular carcinoma progression by modulating HMGB1-ferroptosis axis
by: Xingyang Zhao, et al.
Published: (2025-08-01) -
Production of cycloastragenol in metabolically engineered yeast
by: Jingxian Zhang, et al.
Published: (2025-09-01) -
Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction
by: Sha Zhongxin, et al.
Published: (2025-07-01)